CS logo
small CS logo
Hopital Claude Huriez;Gastro Enterologie

Lille, France
Hospital in Lille
Rue Michel Polonowski, 59000 Lille

About Hopital Claude Huriez;Gastro Enterologie


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
3
Gilead Sciences
2
Rennes University Hospital
2
Takeda
1
Tigenix S.A.U.
1
Total Rows: 5

Clinical Trials at Hopital Claude Huriez;Gastro Enterologie


During the past decade, Hopital Claude Huriez;Gastro Enterologie conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years111111000000Started TrialsCompleted Trails20172018201900.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Treatment of Recurrent Hepatitis C After Liver Transplantation
2002-02-01
2006-07-01
Completed
200
Switch From Tacrolimus to Cyclosporin in the Treatment of Recurrent Hepatitis C After Liver Transplantation
2006-06-01
2009-12-01
Terminated
11
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
2009-04-11
2014-11-18
Completed
1,842
Gilead Sustained Virologic Response (SVR) Registry
2012-04-13
2018-01-08
Completed
6,625
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
2011-12-19
2018-04-09
Completed
570
A Study of Mericitabine in Combination With Telaprevir and Peginterferon Alfa-2a / Ribavirin in Participants With Chronic Hepatitis C
2011-11-30
2014-01-31
Completed
80
Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Participants With Crohn's Disease (CD)
2017-09-15
2023-07-31
Active, not recruiting
554
A Study of Atezolizumab in Combination With Bevacizumab Compared With Sorafenib in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma
2018-03-15
2022-11-17
Completed
558

Rows per page:

1–9 of 9

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Hopital Claude Huriez;Gastro Enterologie" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Gilead Sciences" with 2 trials sponsored, "Rennes University Hospital" with 2 trials sponsored, "Takeda" with 1 trials sponsored and "Tigenix S.A.U." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Claude Huriez;Gastro Enterologie" #1 collaborator was "ANRS, Emerging Infectious Diseases" with 1 trials as a collaborator, "Ministry of Health, France" with 1 trials as a collaborator and "Novartis" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 3Hoffmann-La Roche: 3Gilead Sciences: 2Gilead Sciences: 2Rennes University Hospital: 2Rennes University Hospital: 2Takeda: 1Takeda: 1Tigenix S.A.U.: 1Tigenix S.A.U.: 1

Created with Highcharts 11.1.0Top CollaboratorsANRS, EmergingInfectious Diseases: 1ANRS, EmergingInfectious Diseases: 1Ministry of Health, France: 1Ministry of Health, France: 1Novartis: 1Novartis: 1

Clinical Trials Conditions at Hopital Claude Huriez;Gastro Enterologie


According to Clinical.Site data, the most researched conditions in "Hopital Claude Huriez;Gastro Enterologie" are "Crohn's Disease" (2 trials), "Hepatitis C" (2 trials), "Hepatitis C, Chronic" (2 trials), "Carcinoma, Hepatocellular" (1 trials) and "Chronic Hepatitis C" (1 trials). Many other conditions were trialed in "Hopital Claude Huriez;Gastro Enterologie" in a lesser frequency.

Clinical Trials Intervention Types at Hopital Claude Huriez;Gastro Enterologie


Most popular intervention types in "Hopital Claude Huriez;Gastro Enterologie" are "Drug" (5 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Ribavirin" (2 trials), "Atezolizumab" (1 trials), "Bevacizumab" (1 trials) and "Cx601" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Hopital Claude Huriez;Gastro Enterologie


The vast majority of trials in "Hopital Claude Huriez;Gastro Enterologie" are 9 trials for "All" genders.

Clinical Trials Status at Hopital Claude Huriez;Gastro Enterologie


Currently, there are NaN active trials in "Hopital Claude Huriez;Gastro Enterologie". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Hopital Claude Huriez;Gastro Enterologie, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Hopital Claude Huriez;Gastro Enterologie, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 5Phase 3: 5Phase 2: 1Phase 2: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 6Completed: 6Active, not recruiting: 2Active, not recruiting: 2Terminated: 1Terminated: 1